Keyword

aleglitazar

Description: A pharmacological compound that activates both PPARα and PPARγ receptors and has been investigated for treating metabolic and cardiovascular disorders.
Wikidata ID: wiki/Q3609417
OpenAlex ID: keywords/aleglitazar
2009 · Agnes Bénardeau, Jörg Benz, et al. · Bioorganic & Medicinal Chemistry Letters · 117
2012 · J. P. H. Wilding · Diabetes Obesity and Metabolism · 73
2012 · Sayuri N. Friedland, Aaron Leong, et al. · The American Journal of Medicine · 73
2017 · Sigrid CJ van Steen, Ilse C Schrieks, et al. · European Journal of Preventive Cardiology · 59
2020 · Charikleia Kalliora, Konstantinos Drosatos · Journal of Cardiovascular Pharmacology · 45
2019 · Pitchai Balakumar, Nanjaian Mahadevan, et al. · Current Molecular Pharmacology · 44
2009 · Bernard Charbonnel · The Lancet · 43
2010 · Matthew A. Cavender, A. Michael Lincoff · American Journal of Cardiovascular Drugs · 42
2010 · Matthias Herz, Flavio Gaspari, et al. · International Journal of Cardiology · 39
2013 · Henrik v. Wachenfeldt, Filip Paulsen, et al. · European Journal of Organic Chemistry · 32
2017 · Stefano Savonitto, Nuccia Morici, et al. · Diabetes and Vascular Disease Research · 26
Works count: 106
Citation count: 2,046
Year
Topic
Type